Ocumetics Director and CEO, Dean Burns covers important updates on our first-in-human (FIH) study and what lies ahead. Topics include:

  1. Encouraging outcomes from initial surgeries
  2. Next steps to complete the FIH study
  3. Live Q&A session with Dean Burns

https://youtu.be/rWQnOaq6sVE

  • (Video) Ocumetics Webinar Replay – Successful manufacture of Ocumetics IOL

    Ocumetics Director and CEO, Dean Burns, walks through relevant topics including: Successful manufacture of the Ocumetics IOL Remaining steps to first-in-human study Q&A session Thanks to everyone who joined us for the Webinar. It was an amazing turnout, and it was great to hear your questions and comments. We look forward to hosting more webinars

  • Message from the CEO: August 2024

    Dear Shareholders, Partners, and Visionaries, I am thrilled to share a ground-breaking development from Ocumetics Technology Corp. that marks a monumental step forward in the world of vision enhancement. Today, I am pleased to announce the successful manufacture of our accommodating intraocular lens (IOL) designed to respond to the natural muscle activity of the human

  • (Video) Ocumetics Webinar Replay – Journey to First-In-Human Study

    Ocumetics Director and CEO, Dean Burns, walks through relevant topics including: Manufacturing of the Ocumetics IOL Journey to first-in-human study Q&A session Thanks to everyone who joined us for the Webinar. It was an amazing turnout, and it was great to hear your questions and comments. We look forward to hosting more webinars in the

  • Message from the CEO: July 2024

    Dear Ocumetics Team, Partners and Stakeholders, I am thrilled to share an exciting update in our journey to revolutionize vision correction technology. Last week, we proudly announced, in a separate press release, the commencement of manufacturing for the Ocumetics accommodating intraocular lens (IOL). This is not just a milestone for our corporation, but a significant